EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

WA Hall, E Paulson, XA Li, B Erickson… - CA: a cancer journal …, 2022 - Wiley Online Library
Radiation therapy (RT) continues to play an important role in the treatment of cancer.
Adaptive RT (ART) is a novel method through which RT treatments are evolving. With the …

[HTML][HTML] Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised …

AC Tree, P Ostler, H van der Voet, W Chu… - The Lancet …, 2022 - thelancet.com
Background Localised prostate cancer is commonly treated with external beam radiotherapy
and moderate hypofractionation is non-inferior to longer schedules. Stereotactic body …

Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial

LGW Kerkmeijer, VH Groen, FJ Pos… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE This study investigates whether focal boosting of the macroscopic visible tumor
with external beam radiotherapy increases biochemical disease-free survival (bDFS) in …

Magnetic resonance imaging–guided vs computed tomography–guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial

AU Kishan, TM Ma, JM Lamb, M Casado… - JAMA …, 2023 - jamanetwork.com
Importance Magnetic resonance imaging (MRI) guidance offers multiple theoretical
advantages in the context of stereotactic body radiotherapy (SBRT) for prostate cancer …

[HTML][HTML] COVID-19: Global radiation oncology's targeted response for pandemic preparedness

R Simcock, TV Thomas, C Estes, AR Filippi… - Clinical and …, 2020 - Elsevier
As the global COVID-19 pandemic escalates there is a need within radiation oncology to
work to support our patients in the best way possible. Measures are required to reduce …

Integrated MRI-guided radiotherapy—opportunities and challenges

PJ Keall, C Brighi, C Glide-Hurst, G Liney… - Nature Reviews …, 2022 - nature.com
MRI can help to categorize tissues as malignant or non-malignant both anatomically and
functionally, with a high level of spatial and temporal resolution. This non-invasive imaging …

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised …

P Fransson, P Nilsson, A Gunnlaugsson… - The Lancet …, 2021 - thelancet.com
Summary Background The HYPO-RT-PC trial compared conventionally fractionated
radiotherapy with ultra-hypofractionated radiotherapy in patients with localised prostate …

[HTML][HTML] Prostate cancer radiation therapy recommendations in response to COVID-19

NG Zaorsky, BY James, SM McBride, RT Dess… - Advances in radiation …, 2020 - Elsevier
Purpose During a global pandemic, the benefit of routine visits and treatment of patients with
cancer must be weighed against the risks to patients, staff, and society. Prostate cancer is …

Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

C Draulans, UA van der Heide, K Haustermans… - Radiotherapy and …, 2020 - Elsevier
Background and purpose Local recurrences after radiotherapy for prostate cancer (PCa)
often originate at the location of the macroscopic tumour (s). Since PCa cells are known to …